Background: The Canadian Network for Mood and Anxiety Treatments (CANMAT) has
revised its 2009 guidelines for the management of major depressive disorder (MDD) in …

Objective Psychological distress has a high impact on quality of life in patients with multiple
sclerosis (MS), Parkinson's disease (PD), and Huntington's disease (HD). Studies have …

Objective To determine whether, for patients with depression and Parkinson disease (PD),
telephone-based cognitive-behavioral treatment (T-CBT) alleviates depressive symptoms …

Purpose Multiple sclerosis (MS) is a chronic condition linked to a wide range of
psychological difficulties. While traditional cognitive behavioural therapy has been studied …

BACKGROUND Cognitive-behavioural therapy aims to increase quality of life by changing
cognitive and behavioural factors that maintain problematic symptoms. A previous overview …

Over the decades, pharmaceutical treatments, particularly dopaminergic (DAergic) drugs
have been considered as the main therapy against motor symptoms of Parkinson's disease …

At least one third of patients with active epilepsy suffer from significant impairment of their
emotional well-being. A targeted examination for possible depression (irrespective of any …

Object To systematically evaluate the effects of cognitive behavioral therapy on anxiety and
depression symptoms of patients with Parkinson's disease. Methods Four electronic …

Background For several decades, a myriad of factors have contributed to the inadequate
diagnosis and management of depression in Parkinson's disease (PD), leaving up to 60% of …

Abstract Purpose of Review Depression is prevalent and common among individuals living
with diabetes. The aim of this review is to systematically assess and meta-analyze the …